13D Filing: Sagard Capital Partners, L.P. and Jaguar Health Inc. (JAGX)

Exhibit D

Preferred Stock Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Issuers Current Report on Form 8-K dated March 27, 2018 (the Form 8-K))

Exhibit E

Certificate of Designation (incorporated by reference to Exhibit 3.1 to the Form 8-K)

Exhibit F

Registration Rights Agreement (incorporated by reference to Exhibit 10.2 to the Form 8-K)

Exhibit G

Services Agreement (incorporated by reference to Exhibit 10.4 to the Form 8-K)